Rivaroxaban versus enoxaparin/vit-amin K antagonist therapy in patients with venous thromboembolism and renal impairment - Bauerschs, RM; Lensing, AWA; Prins, MH (Thrombosis Journal 2014;)
Doi: 10.1186/1477-9560-12-25.